Explore more publications!

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on October 28, 2025

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
KFSHRC, 사우디 최초의 유전자·세포치료제 제조 시설 구축 발표
KFSHRC เปิดตัวโรงงานแห่งแรกสำหรับการผลิตยีนและเซลล์บำบัดในซาอุดีอาระเบีย
KFSHRC 将启用沙特阿拉伯首个基因和细胞疗法产品生产基地
KFSHRC 啟用沙特阿拉伯首座基因及細胞治療製造設施
KFSHRC Meluncurkan Fasilitas Pertama untuk Manufaktur Terapi Gen dan Sel di Arab Saudi
KFSHRC、サウジアラビア初の遺伝子・細胞治療製造施設を開設
KFSHRC Melancarkan Fasiliti Pertama untuk Pengeluaran Terapi Gen dan Sel di Arab Saudi
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis
Entrada Therapeutics to Present at Upcoming Investor Conferences
Castle Biosciences to Participate in Upcoming Investor Conferences
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
Verano Holdings Corp. Announces Shareholder Approval to Redomicile Parent Company from British Columbia to Nevada 
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions